These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 10057)
21. Changes in mesolimbic homovanillic acid content following discrete modulation of striatal dopamine systems [proceedings]. Costall B; Naylor RJ Br J Pharmacol; 1979 May; 66(1):105P-106P. PubMed ID: 454900 [No Abstract] [Full Text] [Related]
22. [Effect of carbidine on dopamine turnover in the rat corpus striatum]. Malikova LA; Arefolov VA Farmakol Toksikol; 1980; 43(3):310-3. PubMed ID: 6108865 [TBL] [Abstract][Full Text] [Related]
23. Effect of drugs on metoclopramide-induced catalepsy and increase in striatal homovanillic acid content. Ahtee L Br J Pharmacol; 1975 Mar; 53(3):460P. PubMed ID: 1169083 [No Abstract] [Full Text] [Related]
25. Inhibition by apomorphine of the metoclopramide-induced catalepsy and increase in striatal homovanillic acid content. Ahtee L Br J Pharmacol; 1975 Nov; 55(3):381-5. PubMed ID: 1239323 [TBL] [Abstract][Full Text] [Related]
26. Dopamine and homovanillic acid concentrations in striatal and limbic regions of human brain. Walsh FX; Stevens TJ; Langlais PJ; Bird ED Ann Neurol; 1982 Jul; 12(1):52-5. PubMed ID: 7114818 [TBL] [Abstract][Full Text] [Related]
27. Proceedings: Do anti-psychotic drugs act by dopamine receptor blockade in the nucleus accumbens. Crow TJ; Deakin JF; Longden A Br J Pharmacol; 1975 Oct; 55(2):295P-296P. PubMed ID: 120 [No Abstract] [Full Text] [Related]
29. Neuronal localization of dopamine-sensitive adenylate cyclase within the rat olfactory tubercle. Church AC; Bunney BS; Krieger NR Brain Res; 1982 Feb; 234(2):369-76. PubMed ID: 6800567 [TBL] [Abstract][Full Text] [Related]
30. 3-Methoxytyramine and different neuroleptics: dissociation from HVA and DOPAC. Groppetti A; Parenti M; Galli CL; Bugatti A; Cattabeni F; Di Giulio AM; Racagni G Life Sci; 1978 Oct; 23(17-18):1763-8. PubMed ID: 31531 [No Abstract] [Full Text] [Related]
31. Prostaglandin synthesis inhibition and monoamine metabolites in the rat brain. Abdel-Halim MS; Sjöquist B; Anggård E Prostaglandins; 1979 Dec; 18(6):837-45. PubMed ID: 94946 [TBL] [Abstract][Full Text] [Related]
32. Dissociation of the striatal D-2 dopamine receptor from adenylyl cyclase following 6-hydroxydopamine-induced denervation. Thomas KL; Rose S; Jenner P; Marsden CD Biochem Pharmacol; 1992 Jul; 44(1):73-82. PubMed ID: 1321630 [TBL] [Abstract][Full Text] [Related]
33. Effect of stress and L-DOPA administration on mouse striatal tyramine and homovanillic acid levels. Juorio AV Brain Res; 1979 Dec; 179(1):186-9. PubMed ID: 509231 [No Abstract] [Full Text] [Related]
34. Dopaminergic activity of four analogs of butaclamol. Collu R; Bouvier C; Basak A; Dugas H Pharmacol Res Commun; 1985 Dec; 17(12):1153-7. PubMed ID: 2419927 [TBL] [Abstract][Full Text] [Related]
35. Striatal DOPAC elevation predicts antipsychotic efficacy of metoclopramide. Stanley M; Wilk S Life Sci; 1979 May; 24(20):1907-12. PubMed ID: 459691 [No Abstract] [Full Text] [Related]
36. Adenylate cyclase from various dopaminergic areas of the brain and the action of antipsychotic drugs. Clement-Cormier YC; Robison GA Biochem Pharmacol; 1977 Sep; 26(18):1719-22. PubMed ID: 20110 [No Abstract] [Full Text] [Related]
37. Opiate actions on mesocortical dopamine metabolism in the rat. Kim HS; Iyengar S; Wood PL Life Sci; 1986 Nov; 39(21):2033-6. PubMed ID: 3784768 [TBL] [Abstract][Full Text] [Related]
38. Cyanocyproheptadine: role of cholinolytic properties in modulating neuroleptic-induced elevation of striatal homovanillic acid (HVA). Robinson SE; Lotti VJ; Sulser F J Pharm Pharmacol; 1977 Sep; 29(9):564-6. PubMed ID: 21265 [No Abstract] [Full Text] [Related]
39. Effect of oxotremorine on homovanillic acid concentration in the striatum of the rat. Nose T; Takemoto H Eur J Pharmacol; 1974 Jan; 25(1):51-5. PubMed ID: 4435012 [No Abstract] [Full Text] [Related]
40. Developmental change in striatal concentration of homovanillic acid and 3,4-dihydroxyphenylacetic acid in response to apomorphine and haloperidol treatment. Nomura Y; Komori T; Okuda S; Segawa T Arch Int Pharmacodyn Ther; 1979 Jan; 237(1):25-30. PubMed ID: 485682 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]